MitoKor Files With SEC for Initial Public Offering

Analyst Likes Idec's New Cancer Drug, Ups Revenue Estimate

by Marion Webb, Senior Staff Writer

San Diego-based biotechnology firm MitoKor said recently it filed with the Securities and Exchange Commission for an initial public offering...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99